## Transcript of Health Security Summit

_IMF News, June 9, 2021_

## Source details

**Canonical URL:** [Transcript of Health Security Summit](https://www.imf.org/en/news/articles/2021/06/09/tr060921-transcript-of-health-security-summit)

## Other formats

- [Markdown version](/en/news/articles/2021/06/09/tr060921-transcript-of-health-security-summit/index.md)
- [Structured JSON version](/en/news/articles/2021/06/09/tr060921-transcript-of-health-security-summit/index.json)
- [Bundle manifest](/en/news/articles/2021/06/09/tr060921-transcript-of-health-security-summit/bundle-manifest.json)

## Bibliographic details
- Published: June 9, 2021

---

### IMF plan and vaccine targets
- Plan premise: a two-track pandemic implies a two-track recovery that will hold the world economy back unless vaccinations are accelerated.
- Vaccination targets in the IMF plan:
  - "vaccinate the world to 40 percent by the end of this year, 60 percent by mid next year."
- Plan components:
  - "50 billion dollar price tag" to lift up financing, accelerate production, secure more than is necessary to deal with downside risks, and help the developing world reach vaccination goals.
  - Coordination among IMF, WHO, World Trade Organization, World Bank, and others.
- Expected G-7 outcomes:
  - "upfront commitments in terms of financing as well as early reallocation of vaccines they booked but they don't need."
  - Potential impact: "about a billion doses this year redirected from advanced economies to the developing world."
  - Summit messaging sought: "Vaccinate the world not in 2023, not 2024, but in 2022."

### Economic costs and risks of a two-track recovery
- Quantified economic losses:
  - "nine trillion dollars between now and 2025" in lost output if vaccinations are not accelerated.
  - "40 percent of this would occur in advanced economies."
  - "They would lose one trillion dollars of tax revenues because the rest of the world is being dragged into a pandemic."
- Three principal threats to advanced economies from divergence:
  1. Large lost output and tax revenue shortfalls from a slower global recovery.
  2. Increased risk of viral mutations creating stop-and-go economic performance.
  3. Faster withdrawal of accommodative policies in advanced economies leading to higher interest rates while emerging markets remain weak—creating solvency risk for highly indebted countries (especially with dollar-denominated debt) that could reverberate back to advanced economies.
- Inflation assessment:
  - Current data indicates inflation is "due to primarily supply disruptions that are likely to be overcome."
  - Continued global dysfunction could perpetuate supply chain disruptions and inflationary pressures.

### Special Drawing Rights (SDRs) issuance and use
- Issuance status:
  - The IMF is "very much on track" to issue SDRs; governors are expected to vote on "six hundred and fifty billion dollars."
  - Timeline references: "issuing six hundred and fifty billion dollars in reserve assets by the end of August" and "we expect by mid-August to have the governors voting on six hundred and fifty billion dollars."
- Guidance and deployment:
  - IMF provides "very detailed guidance to countries on how best to use SDRs."
  - IMF encourages directing some SDRs from wealthier nations to those needing help and increasing transparency on SDR deployment.
- China and SDRs:
  - China has indicated interest "to contribute some of their new SDR issuance to a pool of funds at the disposal, or actually the management of the IMF, to be directed to support countries in need."

### Vaccine allocation mechanisms, COVAX, and financing expectations
- COVAX role and limitations:
  - COVAX had the initial objective to deliver "to everybody 20 percent" but recognizes not all countries suffer equally at any one time; COVAX has exceptions and faces logistical pressure.
  - IMF stance: preference for "as much coordination on the allocation of vaccines as possible" with "all hands on deck" if production, contracts, and distribution are transparent and speedy.
- Financing expectations and scale:
  - IMF framing: "50 billion dollars in the context of what that will unlock for the rest of the world is absolutely nothing" compared with larger fiscal packages.
  - Expected financing commitments from G-7: "in the tens of billions, not in the couple of billions."
  - Reallocation potential: IMF analysis shows "one billion doses that are booked in excess of what is necessary in advanced economies. All advanced economies, not just G7."
  - Possible replenishment avenues: discussions on stepping up replenishment of IDA (the concessional grant-lending arm of the World Bank) as part of mobilizing resources.

*Source: Transcript of Health Security Summit, June 9, 2021.*

---


## References

- [https://www.imf.org/en/about/senior-officials/bios/kristalina-georgieva](https://www.imf.org/en/about/senior-officials/bios/kristalina-georgieva)
- [United States and the IMF](http://www.imf.org/external/country/USA/index.htm)
- [Transcripts](https://www.imf.org/en/news/searchnews)
- [PRESS CENTER](http://presscenter.imf.org/)
- [https://www.imf.org/en/home](https://www.imf.org/en/home)

_Source: https://www.imf.org/en/news/articles/2021/06/09/tr060921-transcript-of-health-security-summit_
